On 2026-06-28, INJ trades at $4.624913355610726, sitting 91.2% below its all‑time high of $52.62. The token shows a bearish MACD and RSI of 38.0, indicating weakening momentum despite being off extreme oversold levels. Volume has collapsed to $55.67M, 51.3% below the 30‑day average, signaling fading trader interest. These factors together suggest caution rather than urgency to buy.
Weighted score reflects bearish MACD, low volume, weak fundamentals, but neutral RSI and fixed tokenomics.
Over the past week INJ has fallen 6.68% from $4.8638, and over the last month it is down 30.29% from $6.5106. However, versus 90 days ago the price is up 58.40% from $2.8654, showing a medium‑term rebound that has recently reversed. The short‑term downtrend appears to be regaining dominance.
The 24‑hour volume is $55,670,814.54, compared with a 30‑day average of $114,389,564.08, a deficit of 51.33%. Declining volume often precedes further price drops, as fewer participants are willing to transact at current levels. This trend reinforces the bearish bias seen in the technical indicators.
INJ’s volume‑to‑market‑cap ratio stands at 0.12037 (12.0%). A ratio in the 5‑15% band is typical for liquid assets; INJ is at the upper end, suggesting that while trading activity is relatively healthy versus its size, the absolute volume is still low. The ratio alone does not offset the weakening volume trend.
RSI is 38.0 (neutral‑leaning bearish), down from 41.51 a week ago and far below the 72.55 reading a month ago, indicating deteriorating momentum. MACD is bearish with a line of ‑0.22208948, signal ‑0.16715259 and histogram ‑0.05493689. Price sits below the 20‑day MA ($5.00595) by 7.61% and below the 50‑day MA ($5.26395) by 12.14%, but remains above the 200‑day MA ($4.40145) by 5.08%. Immediate support lies at $4.2214 and $4.8638, while resistance is seen at $5.5224 and $7.0592.
The bid‑ask spread is tight at $0.10, with 100,000 INJ of depth on each side at 1% of the price, reflecting decent liquidity for modest trades. No order‑book imbalance is reported, suggesting balanced buying and selling pressure at the top of the book. However, shallow depth beyond the 1% level could limit larger transactions without slippage.
Injective is an interoperable Layer‑1 blockchain built for DeFi, offering on‑chain financial modules for DEXs, prediction markets and lending, plus cross‑chain bridging to EVM and non‑EVM chains. Development activity is virtually absent: github commits over the last four weeks equal zero, and social metrics show zero Twitter followers and zero Reddit subscribers. This lack of community and code updates raises concerns about long‑term ecosystem health.
INJ has a fixed supply of 100,000,000 tokens, with circulating supply equal to total supply at 100,000,000 INJ. No inflationary emission is programmed, removing dilution risk but also eliminating any built‑in buying pressure from new token issuance. The static supply means price moves depend solely on demand dynamics.
The top three data points driving the DON'T BUY verdict are: INJ is 91.2% below its ATH, highlighting a deep downtrend; 24‑hour volume is down 51.3% versus the 30‑day average, showing waning trader participation; and the MACD is firmly bearish with a negative histogram. Together with an RSI of 38 (approaching weak territory) and negligible development activity, the weight of evidence suggests further downside or prolonged consolidation rather than immediate upside.
Trading Plan
🚫 Do not buy above: 5.522407979604259
🎯 Entry range: 4.22-4.30
🛑 Stop loss: 4.00
💰 Take profit: 5.00
📊 Position size: 2%